Serum Sclerostin Level Among Egyptian Rheumatoid Arthritis Patients: Relation to Bone Mineral Density, Disease Activity and Radiological Grading
Mervat Mahmoud Mostafa Eissa;
Abstract
Background: Bone loss in rheumatoid arthritis (RA) is caused by increased bone resorption, however, there is no increased bone formation. The Wnt pathway is important in the control of bone formation through regulation of osteoblast activity. Sclerostin
Other data
| Title | Serum Sclerostin Level Among Egyptian Rheumatoid Arthritis Patients: Relation to Bone Mineral Density, Disease Activity and Radiological Grading | Other Titles | دراسة عن مستوي السكليروستين بمرضى الروماتويد المصريين وعلاقته بكثافة العظام و نشاط المرض و الأشعة | Authors | Mervat Mahmoud Mostafa Eissa | Keywords | Serum Sclerostin Level Among Egyptian Rheumatoid Arthritis Patients: Relation to Bone Mineral Density, Disease Activity and Radiological Grading | Issue Date | 2013 | Description | Background: Bone loss in rheumatoid arthritis (RA) is caused by increased bone resorption, however, there is no increased bone formation. The Wnt pathway is important in the control of bone formation through regulation of osteoblast activity. Sclerostin |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 120869R9434.pdf | 221.78 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.